ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2025
Functional capacity, quality of life, and disability in fibrosing interstitial lung disease: Insights into pulmonary function and outcomes.
Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Functional mobility under cognitive load in fibrosing interstitial lung disease: a motor-cognitive dual-task study.Therapeutic advances in respiratory diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate lung function, functional capacity, quality of life, functionality, and disability in individuals diagnosed with Fibrosing Interstitial Lung Disease (IFLD).
methodsThe research employed a cross-sectional design and included participants with a confirmed diagnosis of IFLD. Variables under investigation included: 1. Sociodemographic factors; 2. Pulmonary Function; 3. Functional Capacity; 4. Quality of life; 5. Functioning and Disability assessed using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). Ethical approval for the study was obtained from the Research Ethics Committee of the State University of Bahia (UNEB).
resultsThe predicted and observed distances in the six-minute walk test were 545.9±45.2 and 414.5±140.3 meters, respectively. Patients classified with a modified dyspnea scale (mMRC)=4 exhibited a significantly greater impact on functionality. The WHODAS 2.0 domains of social participation and activities of daily living were most affected in IFLD patients. Statistically significant associations were found between the distance covered and WHODAS - locomotion (r=-0.46; p<0.001) as well as between the distance covered and WHODAS-self-care (r=-0.51; p<0.001). In terms of quality of life, mental health and vitality emerged as the most compromised domains.
conclusionThis study revealed a decline in lung function, functional capacity, quality of life, and overall functionality among individuals with IFLD. Notably, the most substantial impairments were identified in domains directly related to quality of life and social interaction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.